Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 850 | 0 | 0 | 0 | 0 |
| Gross Profit | 850 | N/A | N/A | N/A | N/A |
| Operating Expenses | 57,475 | 50,363 | 41,655 | 81,882 | 27,812 |
| Operating Income | -56,625 | -50,363 | -41,655 | -81,882 | -27,812 |
| Other Income | 7,250 | 7,869 | 2,430 | -299 | -1,656 |
| Pre-tax Income | -49,375 | -42,494 | -39,225 | -82,181 | -29,468 |
| Income Tax | N/A | N/A | N/A | N/A | 32 |
| Net Income Continuous | -49,375 | -42,494 | -39,225 | -82,181 | -29,500 |
| Net Income | $-49,375 | $-42,494 | $-39,225 | $-82,181 | $-29,500 |
| EPS Basic Total Ops | -0.36 | -0.33 | -0.37 | -1.31 | -0.96 |
| EPS Basic Continuous Ops | -0.36 | -0.33 | -0.37 | -1.31 | -0.96 |
| EPS Diluted Total Ops | -0.36 | -0.33 | -0.37 | -1.31 | -0.96 |
| EPS Diluted Continuous Ops | -0.36 | -0.33 | -0.37 | -1.31 | -0.96 |
| EPS Diluted Before Non-Recurring Items | -0.36 | -0.33 | -0.37 | -1.31 | -0.96 |
| EBITDA(a) | $-56,523 | $-51,699 | $-40,552 | $-80,258 | $-25,408 |